

浏览全部资源
扫码关注微信
1.新疆医科大学 第五附属医院,乌鲁木齐 830011
2.成都市双流区中医医院,成都 610200
3.成都市双流区第一人民医院,成都 610200
Received:12 March 2021,
Published Online:05 October 2021,
Published:20 November 2021
移动端阅览
王家平,朱红霞,李英.参芪麦味地黄汤联合阿卡波糖对糖耐量异常患者血糖水平、体质量指数及腹部脂肪厚度的影响[J].中国实验方剂学杂志,2021,27(22):108-112.
WANG Jia-ping,ZHU Hong-xia,LI Ying.Effect of Shenqi Maiwei Dihuangtang Combined with Acarbose on Blood Glucose Level,Body Mass Index and Abdominal Fat Thickness in Patients with Impaired Glucose Tolerance[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(22):108-112.
王家平,朱红霞,李英.参芪麦味地黄汤联合阿卡波糖对糖耐量异常患者血糖水平、体质量指数及腹部脂肪厚度的影响[J].中国实验方剂学杂志,2021,27(22):108-112. DOI: 10.13422/j.cnki.syfjx.20212196.
WANG Jia-ping,ZHU Hong-xia,LI Ying.Effect of Shenqi Maiwei Dihuangtang Combined with Acarbose on Blood Glucose Level,Body Mass Index and Abdominal Fat Thickness in Patients with Impaired Glucose Tolerance[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(22):108-112. DOI: 10.13422/j.cnki.syfjx.20212196.
目的
2
探究参芪麦味地黄汤联合阿卡波糖对糖耐量异常(IGT)患者血糖水平、体质量指数(BMI)及腹部脂肪厚度的影响。
方法
2
将2017年2月至2019年1月成都市双流区第一人民医院收治的130例IGT患者纳入研究,应用随机数字表法将患者分为对照组(65例)和研究组(65例)。两组患者均给予饮食调理,运动锻炼常规治疗。对照组在常规治疗的基础上采用口服阿卡波糖治疗,研究组在对照组基础上加用参芪麦味地黄汤治疗。采用全血糖仪测量空腹血糖(FBG),口服葡萄糖耐量试验(OGTT)2 h血糖及糖化血红蛋白(HbA1c)水平;采用超声波断层法测定腹壁脂肪厚度;空腹取静脉血,测量血清总胆固醇(TC),甘油三酯(TG)及脂联素、瘦素水平。
结果
2
治疗后,研究组和对照组的总有效率分别为95.38%(62/65),83.08%(54/65),研究组高于对照组(
χ
2
=5.175,
P
<
0.05)。治疗前,两组IGT患者FBG,2 h OGTT水平,HbA1c,BMI,腰围,腹壁脂肪厚度,TC,TG,脂联素,瘦素比较,差异无统计学意义。治疗后,研究组和对照组IGT患者FBG,2 h OGTT水平,HbA1c,BMI,腰围,腹壁脂肪厚度,TC,TG,瘦素水平均低于治疗前(
P
<
0.05),且研究组低于对照组(
P
<
0.05,
P
<
0.01);两组患者脂联素水平均高于治疗前(
P
<
0.05),且研究组高于对照组(
P
<
0.05)。
结论
2
参芪麦味地黄汤联合阿卡波糖治疗糖耐量异常患者疗效显著,有效降低2 h OGTT水平,降低腹部脂肪厚度,缓解肥胖,改善患者体质。
Objective
2
To explore the effect of Shenqi Maiwei Dihuangtang (SQMWDH) combined with acarbose on the level of 2-hour oral glucose tolerance test (2 h OGTT),body mass index (BMI), and abdominal fat thickness in patients with impaired glucose tolerance (IGT).
Method
2
A total of 130 patients with IGT admitted to the First People's Hospital of Shuangliu District from February 2017 to January 2019 were divided into a control group and a treatment group by a random number table. All patients received conventional treatment, such as diet regulation and exercise. The patients in the control group received additional oral administration of acarbose,while those in the treatment group were treated with SQMWDH based on the control group. Fasting blood glucose (FBG),2 h OGTT, and glycated hemoglobin A1c(HbA1c)levels were measured by the blood glucose meter. Abdominal fat thickness was measured by ultrasound tomography,and serum total cholesterol (TC),triglyceride (TG),adiponectin, and leptin levels in fasting venous blood were measured.
Result
2
After treatment,the total response rate of the treatment group was higher than that of the control group (95.00% vs. 81.67%,
χ
2
=5.175,
P
<
0.05). Before treatment,there was no significant difference in FBG,2 h OGTT,HbA1c, BMI,waist circumference,abdominal fat thickness,TC,TG,adiponectin, and leptin of IGT patients between the two groups. After treatment,the levels of FBG,2 h OGTT,HbA1c, BMI,waist circumference,abdominal fat thickness,TC,TG,and leptin of IGT patients were lower than those before treatment in both groups (
P
<
0.05), and the treatment group was inferior to the control group(
P
<
0.05,
P
<
0.01). The level of adiponectin after treatment was higher than that before treatment in both groups (
P
<
0.05),and the treatment group was superior to the control group (
P
<
0.05).
Conclusion
2
SQMWDH combined with acarbose is effective in treating IGT patients by effectively reducing 2 h OGTT and abdominal fat thickness to alleviate obesity and improve the constitution of patients.
王磊 , 潘化平 , 高真真 , 等 . 二甲双胍对糖耐量异常患者有氧运动能力及运动过程中能量代谢的影响 [J]. 中国康复医学杂志 , 2016 , 31 ( 3 ): 324 - 327 .
高海侠 , 刘晓华 , 张晓月 . 孕期血浆内脂素水平与妊娠期糖耐量异常的关系 [J]. 中国妇幼保健 , 2019 , 34 ( 16 ): 3644 - 3646 .
马宁宁 . 参芪麦味地黄汤加减联合西药治疗老年糖尿病患者的临床观察 [J]. 中医临床研究 , 2017 , 9 ( 5 ): 63 - 65 .
田会萍 , 任乐 , 姚鸿萍 , 等 . 中医“益气养阴”法辅助治疗2型糖尿病的Meta分析 [J]. 世界中医药 , 2019 , 14 ( 5 ): 1192 - 1197 .
张海力 , 王丽丽 , 李靖 , 等 . 益气养阴活血法联合现代医学治疗早期糖尿病肾病的Meta分析 [J]. 世界中医药 , 2020 , 15 ( 21 ): 3280 - 3279 .
夏静 , 王海明 , 沈金花 , 等 . 参芪麦味地黄汤联合二甲双胍对气阴两虚型2型糖尿病患者UACR、MODD及血流动力学的影响 [J]. 中医药学报 , 2020 , 48 ( 2 ): 12 - 16 .
中华医学会糖尿病学分会 . 中国2型糖尿病防治指南(2013年版) [J]. 中华内分泌代谢杂志 , 2014 , 30 ( 10 ): 893 - 942 .
贾爱华 , 徐少勇 , 明洁 , 等 . 我国不同诊断标准下肥胖流行病学特征分析 [J]. 中国糖尿病杂志 , 2017 , 9 ( 4 ): 221 - 225 .
孙传兴 . 临床疾病诊断依据治愈好转标准 [M]. 2版 . 北京 : 人民军医出版社 , 1998 : 77 - 78 .
卢伟炽 , 许帅 , 朱章志 , 等 . 2型糖尿病中医临床路径的应用效果 [J]. 世界中医药 , 2019 , 14 ( 6 ): 1594 - 1597 .
李 霞 , 娄金波 , 陈永华 , 等 . 参芪麦味地黄汤治疗糖尿病早期肾病临床观察 [J]. 亚太传统医药 , 2016 , 12 ( 5 ): 141 - 142 .
王威 , 王艺颖 , 马健 , 等 . 银离子敷料在糖尿病足治疗中的应用进展 [J]. 中华现代护理杂志 , 2018 , 24 ( 30 ): 3718 - 3720 .
潘洪 . 阿卡波糖治疗老年冠心病合并糖耐量减低35例 [J]. 中国药业 , 2008 , 17 ( 3 ): 40 - 42 .
白晓寒 , 黄延芹 , 徐云生 . 现代医家对糖尿病中医病机的认识 [J]. 光明中医 , 2015 , 30 ( 1 ): 206 - 209 .
马燕 , 张晶 , 王亚 , 等 . 黄芪降糖颗粒降糖作用实验研究 [J]. 中国实验方剂学杂志 , 2011 , 17 ( 8 ): 157 - 160 .
谢庆 , 侯敏 , 张子玥 , 等 . 冮顺奎应用茯苓四逆汤治疗不寐经验总结 [J]. 中医药导报 , 2018 , 25 ( 13 ): 105 - 106 .
伍曦 , 方灿 . 乳癖消片中哈巴俄苷和肉桂酸的HPLC测定及不同厂家间样品含量比较分析 [J]. 贵州医药 , 2018 , 42 ( 6 ): 668 - 669 .
汪征 , 李自成 , 陈小明 , 等 . 阿卡波糖对冠心病伴糖耐量受损患者血清脂联素和瘦素水平的影响 [J]. 临床心血管病杂志 , 2014 , 30 ( 3 ): 244 - 247 .
赵宝珍 , 谢晓云 , 张晓瑞 . 糖耐量受损大鼠血清脂联素瘦素与冠状动脉病变的关系 [J]. 中国药物与临床 , 2006 , 6 ( 6 ): 408 - 410 .
0
Views
18
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621